SI1742957T1 - Postopek za pripravo telitromicina - Google Patents

Postopek za pripravo telitromicina

Info

Publication number
SI1742957T1
SI1742957T1 SI200530112T SI200530112T SI1742957T1 SI 1742957 T1 SI1742957 T1 SI 1742957T1 SI 200530112 T SI200530112 T SI 200530112T SI 200530112 T SI200530112 T SI 200530112T SI 1742957 T1 SI1742957 T1 SI 1742957T1
Authority
SI
Slovenia
Prior art keywords
formula
xiia
benzoyl
preparation
deoxy
Prior art date
Application number
SI200530112T
Other languages
English (en)
Inventor
Suhas Sohani
Mandar Deodhar
Nishant Patel
Manish Patel
Mahesh Davadra
Vinodkumar Kansal
Original Assignee
Alembic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alembic Ltd filed Critical Alembic Ltd
Publication of SI1742957T1 publication Critical patent/SI1742957T1/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SI200530112T 2004-04-28 2005-04-25 Postopek za pripravo telitromicina SI1742957T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN491MU2004 2004-04-28
EP05775551A EP1742957B1 (en) 2004-04-28 2005-04-25 Process for the preparation of telithromycin

Publications (1)

Publication Number Publication Date
SI1742957T1 true SI1742957T1 (sl) 2008-04-30

Family

ID=35159987

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200530112T SI1742957T1 (sl) 2004-04-28 2005-04-25 Postopek za pripravo telitromicina

Country Status (10)

Country Link
US (1) US20070260066A1 (sl)
EP (1) EP1742957B1 (sl)
AT (1) ATE373009T1 (sl)
AU (1) AU2005238313A1 (sl)
CA (1) CA2559281A1 (sl)
DE (1) DE602005002475T2 (sl)
ES (1) ES2294733T3 (sl)
PL (1) PL1742957T3 (sl)
SI (1) SI1742957T1 (sl)
WO (1) WO2005105821A2 (sl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2801100A1 (en) 2003-03-10 2004-09-23 Optimer Pharmaceuticals, Inc. Macrolides and processes for their preparation
WO2007039914A2 (en) * 2005-10-06 2007-04-12 Alembic Limited Novel polymorphs of telithromycin
WO2007049296A2 (en) * 2005-10-28 2007-05-03 Alembic Limited Amorphous form of telithromycin
WO2007059307A2 (en) * 2005-11-15 2007-05-24 Teva Pharmaceutical Industries Ltd. Crystalline and amorphous forms of telithromycin
WO2007069264A2 (en) * 2005-12-15 2007-06-21 Alembic Limited Reference standards for determining the purity of telithromycin and processes therefor
GB0600238D0 (en) 2006-01-06 2006-02-15 Sandoz Ag Organic compounds
WO2008007388A1 (en) * 2006-07-12 2008-01-17 Alembic Limited Novel process for the preparation of telithromycin
WO2008023383A1 (en) * 2006-08-25 2008-02-28 Alembic Limited Novel process for the preparation of telithromycin
ES2306590B1 (es) * 2006-12-15 2009-08-07 Ercros Industrial,S .A. Formas cristalinas i y ii de telitromicina.
ES2310121B1 (es) * 2007-04-19 2009-09-11 Ercros Industrial, S.A. Nuevo proceso de sintesis de telitromicina.
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
WO2009053259A1 (en) * 2007-10-25 2009-04-30 Sandoz Ag Process for the production of telithromycin
SI2358379T1 (sl) 2008-10-24 2016-05-31 Cempra Pharmaceuticals, Inc. Postopki biološke obrambe z makrolidi, ki vsebujejo triazol
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
RU2650883C2 (ru) 2010-03-22 2018-04-18 Семпра Фармасьютикалз, Инк. Кристаллические формы макролида и их применение
EP2571506B1 (en) 2010-05-20 2017-05-10 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
IN2014DN08939A (sl) 2012-03-27 2015-05-22 Cempra Pharmaceuticals Inc
EP2968801B1 (en) 2013-03-14 2018-09-26 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL114589A (en) * 1990-11-21 1999-12-22 Roussel Uclaf Intermediates for the preparation of the history of erythromycin
FR2719587B1 (fr) * 1994-05-03 1996-07-12 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
FR2732684B1 (fr) * 1995-04-06 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments

Also Published As

Publication number Publication date
DE602005002475T2 (de) 2008-05-29
AU2005238313A1 (en) 2005-11-10
CA2559281A1 (en) 2005-11-10
EP1742957A2 (en) 2007-01-17
US20070260066A1 (en) 2007-11-08
EP1742957B1 (en) 2007-09-12
PL1742957T3 (pl) 2008-05-30
DE602005002475D1 (de) 2007-10-25
WO2005105821A2 (en) 2005-11-10
ES2294733T3 (es) 2008-04-01
WO2005105821A3 (en) 2006-04-27
ATE373009T1 (de) 2007-09-15

Similar Documents

Publication Publication Date Title
SI1742957T1 (sl) Postopek za pripravo telitromicina
MY142768A (en) Gfat inhibitors
NO20082338L (no) Pyrimidinderivater for behandling av avvikende cellevekst
MX2010006179A (es) Formas solidas de acido 3-(6-(1-(2,2-difluorobenzo[d] [1,3]dioxol-5-il)ciclopropancarboxamido)-3-metilpiridin-2-il)benz oico.
NZ601786A (en) Novel compounds and compositions and methods of use
WO2007135527A3 (en) Benzimidazolyl compounds
NO20064077L (no) Kemokinreseptorantagonister
MX2008016423A (es) Arilamidas sustituidas con tetrazol.
UA85698C2 (ru) Хинолиновые промежуточные соединения для синтеза ингибиторов рецепторной тирозинкиназы и способ их получения
WO2005082892A3 (en) Triazole compounds as antibacterial agents and pharmaceutical compositions containing them
DE602005019316D1 (en) Aromatische etherderivate als thrombin-hemmer
IL176547A0 (en) 1,3,5-trisubstituted 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity
GEP20115171B (en) Polymorphs of benzoate salt of 2-[[6-[(3r)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2h)-pyrimidinyl]methyl]-benzonitrile and methods of use therefor
WO2007084914A3 (en) Phenoxy-substituted pyrimidines as adenosine receptor antagonists
TW200607801A (en) Pyrimidine derivatives for the treatment of abnormal cell growth
MY148636A (en) Benzimidazole derivatives
TW200512206A (en) 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridin-2-yl-amion]-propionic acid ethylester-methanesulfonate and its use as a medicament
TW200702330A (en) 3,4,5-Substituted piperidines
WO2004050637A3 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
PT2049480E (pt) Derivados de 2-arilindole como inibidores da mpges-i
ATE374190T1 (de) Tetrahydrochinazolinderivate als cfr-antagonisten
MY186650A (en) Heteroaryl pyrrolidinyl and piperidinyl ketone derivatives
WO2005077902A3 (en) Methods for the synthesis of pyridoxamine
MXPA05013751A (es) Procedimiento e intermediarios para la preparacion de 3-(amino)-3-ciclobutilmetil-2-hidroxi-propionamida o sus sales.
TNSN07006A1 (en) Novel heterocyclic compounds